1. Home
  2. OSPN vs SLDB Comparison

OSPN vs SLDB Comparison

Compare OSPN & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$12.33

Market Cap

576.4M

Sector

Technology

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$5.92

Market Cap

464.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSPN
SLDB
Founded
1991
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
576.4M
464.1M
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
OSPN
SLDB
Price
$12.33
$5.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
11
Target Price
$17.00
$14.82
AVG Volume (30 Days)
591.9K
1.1M
Earning Date
10-30-2025
11-03-2025
Dividend Yield
3.90%
N/A
EPS Growth
99.92
N/A
EPS
1.49
N/A
Revenue
$241,436,000.00
N/A
Revenue This Year
$1.91
N/A
Revenue Next Year
$3.49
N/A
P/E Ratio
$8.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.00
$2.41
52 Week High
$20.37
$7.37

Technical Indicators

Market Signals
Indicator
OSPN
SLDB
Relative Strength Index (RSI) 41.52 64.94
Support Level $12.05 $4.92
Resistance Level $12.55 $5.45
Average True Range (ATR) 0.36 0.36
MACD 0.14 0.16
Stochastic Oscillator 59.67 99.16

Price Performance

Historical Comparison
OSPN
SLDB

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: